Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Paxton

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Clinical and Experimental Pharmacology & Physiology|May 1, 1982
The protein binding and elimination of methotrexate after intravenous infusions in cancer patientsJ W Paxton
The New Zealand Medical Journal|February 24, 1982
Elementary pharmacokinetics in clinical practice. 5: The effect of pathological condition on pharmacokineticsJ W Paxton
Epilepsia|April 1, 1982
Carbamazepine determination in saliva of children: enzyme immunoassay (EMIT) versus high pressure liquid chromatographyJ W Paxton
The New Zealand Medical Journal|April 10, 1985
Drug binding to plasma proteinsJ W Paxton
The New Zealand Medical Journal|October 28, 1981
Elementary pharmacokinetics in clinical practice I: drug absorption and dispositionJ W Paxton
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1983
Alpha 1 -acid glycoprotein and binding of basic drugsJ W Paxton
The Journal of Pharmacy and Pharmacology|November 1, 1986
The effect of food on the bioavailability and kinetics of the anticancer drug amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]-4 acridinecarboxamide in rabbitsJ W Paxton
Journal of Pharmacological Methods|May 1, 1981
Protein binding of methotrexate in sera from normal human beings: effect of drug concentration, pH, temperature, and storageJ W Paxton
Australian and New Zealand Journal of Medicine|December 1, 1979
High-dose methotrexate therapy--an area of uncertaintyJ W Paxton
Pharmacology|January 1, 1983
Absence of effect of propoxyphene on antipyrine kinetics in the rabbitJ W Paxton
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Clinical and Experimental Pharmacology & Physiology|May 1, 1982
The protein binding and elimination of methotrexate after intravenous infusions in cancer patientsJ W Paxton
The New Zealand Medical Journal|February 24, 1982
Elementary pharmacokinetics in clinical practice. 5: The effect of pathological condition on pharmacokineticsJ W Paxton
Epilepsia|April 1, 1982
Carbamazepine determination in saliva of children: enzyme immunoassay (EMIT) versus high pressure liquid chromatographyJ W Paxton
The New Zealand Medical Journal|April 10, 1985
Drug binding to plasma proteinsJ W Paxton
The New Zealand Medical Journal|October 28, 1981
Elementary pharmacokinetics in clinical practice I: drug absorption and dispositionJ W Paxton
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1983
Alpha 1 -acid glycoprotein and binding of basic drugsJ W Paxton
The Journal of Pharmacy and Pharmacology|November 1, 1986
The effect of food on the bioavailability and kinetics of the anticancer drug amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]-4 acridinecarboxamide in rabbitsJ W Paxton
Journal of Pharmacological Methods|May 1, 1981
Protein binding of methotrexate in sera from normal human beings: effect of drug concentration, pH, temperature, and storageJ W Paxton
Australian and New Zealand Journal of Medicine|December 1, 1979
High-dose methotrexate therapy--an area of uncertaintyJ W Paxton
Pharmacology|January 1, 1983
Absence of effect of propoxyphene on antipyrine kinetics in the rabbitJ W Paxton
Pageof 11